| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |